Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170

1.

BAP1 Loss Is Associated with DNA Methylomic Repatterning in Highly Aggressive Class 2 Uveal Melanomas.

Field MG, Kuznetsov JN, Bussies PL, Cai LZ, Alawa KA, Decatur CL, Kurtenbach S, Harbour JW.

Clin Cancer Res. 2019 Sep 15;25(18):5663-5673. doi: 10.1158/1078-0432.CCR-19-0366. Epub 2019 Jul 8.

PMID:
31285370
2.

HDAC Inhibition Enhances the In Vivo Efficacy of MEK Inhibitor Therapy in Uveal Melanoma.

Faião-Flores F, Emmons MF, Durante MA, Kinose F, Saha B, Fang B, Koomen JM, Chellappan SP, Maria-Engler SS, Rix U, Licht JD, Harbour JW, Smalley KSM.

Clin Cancer Res. 2019 Sep 15;25(18):5686-5701. doi: 10.1158/1078-0432.CCR-18-3382. Epub 2019 Jun 21.

PMID:
31227503
3.

Integrative Copy Number Analysis of Uveal Melanoma Reveals Novel Candidate Genes Involved in Tumorigenesis Including a Tumor Suppressor Role for PHF10/BAF45a.

Anbunathan H, Verstraten R, Singh AD, Harbour JW, Bowcock AM.

Clin Cancer Res. 2019 Aug 15;25(16):5156-5166. doi: 10.1158/1078-0432.CCR-18-3052. Epub 2019 Jun 21.

PMID:
31227497
4.

Genomic evolution of uveal melanoma arising in ocular melanocytosis.

Durante MA, Field MG, Sanchez MI, Covington KR, Decatur CL, Dubovy SR, Harbour JW.

Cold Spring Harb Mol Case Stud. 2019 Aug 1;5(4). pii: a004051. doi: 10.1101/mcs.a004051. Print 2019 Aug.

5.

Vitreoretinal lymphoma followed by systemic diffuse large B cell lymphoma.

Fan KC, Tran KD, Harbour JW, Dubovy SA, Patel NA, Albini TA.

J Ophthalmic Inflamm Infect. 2019 Jun 10;9(1):11. doi: 10.1186/s12348-019-0177-8.

6.

An Eight-Year-Old Girl Presents With Two Weeks of Vision Loss and Nightly Headaches.

Scott NL, Tran KD, Cernichiaro-Espinosa LA, Russell JF, Hinkle JW, Harbour JW, Dubovy SR, Berrocal AM.

Ophthalmic Surg Lasers Imaging Retina. 2019 May 1;50(5):314-317. doi: 10.3928/23258160-20190503-09.

PMID:
31100163
7.

Longitudinal Examination of Fellow-Eye Vascular Anomalies in Coats' Disease With Widefield Fluorescein Angiography: A Multicenter Study.

Jeng-Miller KW, Soomro T, Scott NL, Rao P, Marlow E, Chang EY, Ells A, Chau F, Nudleman E, Calvo CM, Patel N, Schwartz R, Cernichiaro-Espinosa LA, Montoya AG, Goldstein J, Harper CA 3rd, Baumal CR, Hartnett ME, Harbour JW, Besirli CG, Gupta MP, Chan RVP, Drenser KA, Capone A Jr, Murray TG, Mukai S, Trese MT, Berrocal AM, Wong SC, Yonekawa Y.

Ophthalmic Surg Lasers Imaging Retina. 2019 Apr 1;50(4):221-227. doi: 10.3928/23258160-20190401-04.

8.

Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.

Dean MK, Studenski MT, Paez-Escamilla MA, Walter SD, Kwon D, Markoe AM, Harbour JW, Samuels SE.

Brachytherapy. 2019 May - Jun;18(3):404-410. doi: 10.1016/j.brachy.2019.01.005. Epub 2019 Feb 20.

PMID:
30797699
9.

Bilateral radiation therapy followed by methotrexate-based chemotherapy for primary vitreoretinal lymphoma.

de la Fuente MI, Alderuccio JP, Reis IM, Omuro A, Markoe A, Echegaray JJ, Davis JL, Harbour JW, Lossos IS.

Am J Hematol. 2019 Apr;94(4):455-460. doi: 10.1002/ajh.25414. Epub 2019 Feb 4.

PMID:
30663807
10.

Drug and disease signature integration identifies synergistic combinations in glioblastoma.

Stathias V, Jermakowicz AM, Maloof ME, Forlin M, Walters W, Suter RK, Durante MA, Williams SL, Harbour JW, Volmar CH, Lyons NJ, Wahlestedt C, Graham RM, Ivan ME, Komotar RJ, Sarkaria JN, Subramanian A, Golub TR, Schürer SC, Ayad NG.

Nat Commun. 2018 Dec 14;9(1):5315. doi: 10.1038/s41467-018-07659-z.

11.

Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide.

Walpole S, Pritchard AL, Cebulla CM, Pilarski R, Stautberg M, Davidorf FH, de la Fouchardière A, Cabaret O, Golmard L, Stoppa-Lyonnet D, Garfield E, Njauw CN, Cheung M, Turunen JA, Repo P, Järvinen RS, van Doorn R, Jager MJ, Luyten GPM, Marinkovic M, Chau C, Potrony M, Höiom V, Helgadottir H, Pastorino L, Bruno W, Andreotti V, Dalmasso B, Ciccarese G, Queirolo P, Mastracci L, Wadt K, Kiilgaard JF, Speicher MR, van Poppelen N, Kilic E, Al-Jamal RT, Dianzani I, Betti M, Bergmann C, Santagata S, Dahiya S, Taibjee S, Burke J, Poplawski N, O'Shea SJ, Newton-Bishop J, Adlard J, Adams DJ, Lane AM, Kim I, Klebe S, Racher H, Harbour JW, Nickerson ML, Murali R, Palmer JM, Howlie M, Symmons J, Hamilton H, Warrier S, Glasson W, Johansson P, Robles-Espinoza CD, Ossio R, de Klein A, Puig S, Ghiorzo P, Nielsen M, Kivelä TT, Tsao H, Testa JR, Gerami P, Stern MH, Paillerets BB, Abdel-Rahman MH, Hayward NK.

J Natl Cancer Inst. 2018 Dec 1;110(12):1328-1341. doi: 10.1093/jnci/djy171.

PMID:
30517737
12.

CD4+/CD8+ immunophenotype switching as a marker for intraocular and CNS involvement in mycosis fungoides.

Husnain M, Mackrides N, Vega F, Paez-Escamilla M, Markoe AM, Harbour JW, Lossos IS.

Leuk Lymphoma. 2019 May;60(5):1308-1311. doi: 10.1080/10428194.2018.1526376. Epub 2018 Nov 14. No abstract available.

PMID:
30424702
13.

Diagnosis of Bilateral Retinocytoma in an Adolescent Patient Using Multimodal Imaging and Genetic Testing.

Paez-Escamilla M, Walter SD, Ramaiya KJ, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2018 Oct 1;49(10):812-814. doi: 10.3928/23258160-20181002-11.

PMID:
30395669
14.

ChIPprimersDB: a public repository of verified qPCR primers for chromatin immunoprecipitation (ChIP).

Kurtenbach S, Reddy R, Harbour JW.

Nucleic Acids Res. 2019 Jan 8;47(D1):D46-D49. doi: 10.1093/nar/gky813.

15.

Are Risk Factors for Growth of Choroidal Nevi Associated With Malignant Transformation? Assessment With a Validated Genomic Biomarker.

Harbour JW, Paez-Escamilla M, Cai L, Walter SD, Augsburger JJ, Correa ZM.

Am J Ophthalmol. 2019 Jan;197:168-179. doi: 10.1016/j.ajo.2018.08.045. Epub 2018 Sep 7.

PMID:
30195895
16.

Persistent fetal vasculature presenting with axial elongation and platyphakia.

Lin J, Paez-Escamilla M, Teira LE, Fallas B, Harbour JW.

J AAPOS. 2019 Feb;23(1):51-53. doi: 10.1016/j.jaapos.2018.06.005. Epub 2018 Aug 31.

PMID:
30176292
17.

Gene Expression Profiling and PRAME Status Versus Tumor-Node-Metastasis Staging for Prognostication in Uveal Melanoma.

Cai L, Paez-Escamilla M, Walter SD, Tarlan B, Decatur CL, Perez BM, Harbour JW.

Am J Ophthalmol. 2018 Nov;195:154-160. doi: 10.1016/j.ajo.2018.07.045. Epub 2018 Aug 6.

PMID:
30092184
18.

Reduced BAP1 activity prevents ASXL1 truncation-driven myeloid malignancy in vivo.

Guo Y, Yang H, Chen S, Zhang P, Li R, Nimer SD, Harbour JW, Xu M, Yang FC.

Leukemia. 2018 Aug;32(8):1834-1837. doi: 10.1038/s41375-018-0126-9. Epub 2018 Apr 2. No abstract available.

19.

Congenital Hypertrophy of the Retinal Pigment Epithelium Presenting With Secondary Choroidal Neovascularization.

Garoon RB, Harbour JW.

Ophthalmic Surg Lasers Imaging Retina. 2018 Apr 1;49(4):276-277. doi: 10.3928/23258160-20180329-12.

PMID:
29664987
20.

Anterior Chamber Chemotherapy in Retinoblastoma-Necessary But Not Sufficient for Aqueous Seeding Control-Reply.

Harbour JW, Paez-Escamilla M.

JAMA Ophthalmol. 2018 May 1;136(5):597. doi: 10.1001/jamaophthalmol.2018.0639. No abstract available.

PMID:
29596550

Supplemental Content

Loading ...
Support Center